Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?
Andreas Calatzis, Managing Director of Eonis GmbH and Dynabyte GmbH, shared a post on LinkedIn:
“What is the rationale for collagen-induced platelet aggregation testing?
When we developed the Multiplate analyzer more than 20 years ago, collagen was one of the available agonists alongside ADP, arachidonic acid and TRAP-6.
Although the collagen reagent was used by many laboratories, I never fully understood why it was used.
With the IVDR, manufacturers are expected to define a clear intended purpose and demonstrate the analytical and clinical performance of the device.
So I’d be interested in hearing the community’s views:
- Does collagen-induced platelet aggregation still have a meaningful role alongside ADP, arachidonic acid and TRAP-6?
- If so, what could the intended use actually be?
The answer to the second question will immediately lead to the next one:
Can this intended use be demonstrated in analytical and clinical performance studies?
I’d be very interested to hear how clinicians, laboratory physicians and researchers see the role of collagen-induced platelet aggregation today.”
Find more posts featuring Andreas Calatzis on Hemostasis Today.
-
Nov 19, 2026, 22:24Erik Nelson: Low Iron Can Raise A1c without Changing Blood Sugar
-
Nov 19, 2026, 22:23Erwin Loh: Daily Iron Supplementation Reduces Iron-Deficiency Anaemia in Children and Adolescents
-
Nov 19, 2026, 22:22Afifah Sardar: Why Can a Simple Painkiller like Aspirin Make You Bleed More?
-
Nov 19, 2026, 22:16Jonathan Penm: Perioperative Anticoagulation Management and Antithrombotic Stewardship Across 31 Countries
-
Nov 19, 2026, 22:15Salomao V.: Innovation in Hemophilia A Is Also About How Patients Receive Their Treatment
-
Nov 19, 2026, 16:27263 PolyU Students and Staff Unite to Donate Blood – Hong Kong Red Cross Blood Transfusion Service
-
Nov 19, 2026, 16:16Billy Otieno: The Future of Blood Donation Lies Beyond Collection
-
Nov 19, 2026, 15:58Hema Goyal: Hematocon 2026 Bringing Together Knowledge, Innovation and Excellence in Hematology
-
Nov 19, 2026, 15:44Chukwuemeka Amarachi: Understanding Complex Blood Grouping Beyond Routine ABO And RhD Typing